Scalable production in single-use bioreactors

Jonathan Zmuda, Ph.D. is a Director of Cell Biology R&D within the Biosciences Division of Thermo Fisher Scientific located in Frederick, MD (USA). Within Cell Biology, Jon leads various teams that focus on developing new technologies for protein expression, viral vector production, transfection and classical cell culture. Dr. Zmuda received his Ph.D. in Cell Biology from the University of Maryland, College Park and his undergraduate degree from Dickinson College in Carlisle, PA.

Dr. Premkumar Jayaraman currently provides technical consultation for Thermo Fisher Scientific’s cell and gene therapy solutions such as the Gibco Cell Therapy Systems (CTS) brand of products. Prem has over a decade of expertise in synthetic biology utilizing gene-editing technologies, stem cell bioprocessing (pluripotent and adult stem cells), and viral vector production (lentivirus and adeno-associated viruses). In his previous role as a Research Scientist at the Bioprocessing Technology Institute (A*STAR, Singapore), Prem oversaw a variety of cell and gene therapy projects, from media optimization to upstream process development. Prem received his doctoral degree in Biotechnology from Nanyang Technological University (Singapore). He is currently pursuing his Professional MBA at Nanyang Business School.